Shariah screening · industry
Halal Biotechnology Stocks
144 Biotechnology issuers carry a screening verdict, out of 755 issuers we hold in this industry. Verdicts come from two independent engines and each row says which.
Verdict split
57 compliant 8%
87 non-compliant 12%
611 no verdict yet 81%
151 screened by our own engine against published ratio methodologies computed from primary filings · 50 carrying a reviewed third-party provider verdict.
Classified under Healthcare.
Do the standards agree here?
The seven standards HTR computes reach different verdicts on 92 of the 498 Biotechnology issuers that more than one of them can decide — 18%.
A split is one issuer at least one standard passes and at least one fails. Why they disagree is mostly the denominator each standard measures debt against, not the ceiling.
Screened issuers
Compliant first, then the other verdicts, then the issuers with no verdict yet; alphabetical within each. Every row links to that issuer's full ratio breakdown, business-activity screen and the filing behind it.
| Issuer | Verdict | Screened | Source |
|---|---|---|---|
| 298380.KQ ABL Bio Inc. | COMPLIANT | 2026-08-27 | in-house |
| ABSI Absci Corp | COMPLIANT | 2026-11-09 | provider |
| ACAD Acadia Pharmaceuticals Inc | COMPLIANT | 2026-11-09 | provider |
| ADMA Adma Biologics Inc | COMPLIANT | 2026-11-09 | provider |
| TCRT Alaunos Therapeutics Inc | COMPLIANT | 2026-11-09 | provider |
| ALNY Alnylam Pharmaceuticals Inc | COMPLIANT | 2026-11-09 | provider |
| 4563.T AnGes, Inc. | COMPLIANT | 2026-08-26 | in-house |
| ANTHEM.NS Anthem Biosciences Limited | COMPLIANT | 2026-08-28 | in-house |
| RCUS Arcus Biosciences Inc | COMPLIANT | 2026-11-09 | provider |
| AUPH Aurinia Pharmaceuticals Inc | COMPLIANT | 2026-11-09 | provider |
| 300318.SZ Beijing Bohui Innovation Biotechnology Group Co., Ltd. | COMPLIANT | 2026-08-26 | in-house |
| 603392.SS Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. | COMPLIANT | 2026-08-26 | in-house |
| ONC BeOne Medicines Ltd. American Depositary Shares | COMPLIANT | 2026-11-09 | provider |
| TECH Bio-Techne Corp | COMPLIANT | 2026-11-09 | provider |
| BIOCON.NS Biocon Limited | COMPLIANT | 2026-08-26 | in-house |
| BSEM BioStem Technologies Inc | COMPLIANT | 2026-11-09 | provider |
| BLUEJET.NS Blue Jet Healthcare Limited | COMPLIANT | 2026-08-27 | in-house |
| BBIO BridgeBio Pharma Inc | COMPLIANT | 2026-11-09 | provider |
| 068270.KS Celltrion, Inc. | COMPLIANT | 2026-08-27 | in-house |
| CONCORDBIO.NS Concord Biotech Limited | COMPLIANT | 2026-08-26 | in-house |
| CSL.AX CSL Limited | COMPLIANT | 2026-08-27 | in-house |
| 2616.HK CStone Pharmaceuticals | COMPLIANT | 2026-08-27 | in-house |
| CUE Cue Biopharma Inc | COMPLIANT | 2026-11-09 | provider |
| GDTC CytoMed Therapeutics Limited | COMPLIANT | 2026-08-28 | in-house |
| ESLA Estrella Immunopharma Inc | COMPLIANT | 2026-11-09 | provider |
| 1952.HK Everest Medicines Limited | COMPLIANT | 2026-08-27 | in-house |
| FYB.F Formycon AG | COMPLIANT | 2026-08-27 | in-house |
| 1548.HK Genscript Biotech Corporation | COMPLIANT | 2026-08-27 | in-house |
| 2160.T GNI Group Ltd. | COMPLIANT | 2026-08-26 | in-house |
| GUBRA.CO Gubra A/S | COMPLIANT | 2026-08-27 | in-house |
| GYRE Gyre Therapeutics Inc | COMPLIANT | 2026-11-09 | provider |
| 300255.SZ Hebei Changshan Biochemical Pharmaceutical Co., Ltd. | COMPLIANT | 2026-08-26 | in-house |
| 028300.KQ HLB Co., Ltd. | COMPLIANT | 2026-08-27 | in-house |
| ICCC Immucell Corp. | COMPLIANT | 2026-11-09 | provider |
| LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B | COMPLIANT | 2026-11-09 | provider |
| MAB.WA Mabion S.A. | COMPLIANT | 2026-08-28 | in-house |
| MTNB Matinas Biopharma Holdings Inc | COMPLIANT | 2026-11-09 | provider |
| MAZE Maze Therapeutics, Inc. | COMPLIANT | 2026-11-09 | provider |
| MEDCL.PA MedinCell S.A. | COMPLIANT | 2026-08-27 | in-house |
| MESO Mesoblast Ltd - ADR | COMPLIANT | 2026-11-09 | provider |
| MIRM Mirum Pharmaceuticals Inc | COMPLIANT | 2026-11-09 | provider |
| NANO.PA Nanobiotix S.A. | COMPLIANT | 2026-08-27 | in-house |
| NWRN.SW Newron Pharmaceuticals S.p.A. | COMPLIANT | 2026-08-27 | in-house |
| NWBO Northwest Biotherapeutics Inc | COMPLIANT | 2026-11-09 | provider |
| NRXP NRX Pharmaceuticals Inc | COMPLIANT | 2026-11-09 | provider |
| 1477.HK Ocumension Therapeutics | COMPLIANT | 2026-08-27 | in-house |
| PANACEABIO.BO Panacea Biotec Limited | COMPLIANT | 2026-08-28 | in-house |
| 214450.KQ PharmaResearch Co., Ltd. | COMPLIANT | 2026-08-27 | in-house |
| TXTM Protext Pharma Inc | COMPLIANT | 2026-11-09 | provider |
| SANN.SW Santhera Pharmaceuticals Holding AG | COMPLIANT | 2026-08-28 | in-house |
| 1877.HK Shanghai Junshi Biosciences Co., Ltd. | COMPLIANT | 2026-08-27 | in-house |
| 326030.KS SK Biopharmaceuticals Co., Ltd. | COMPLIANT | 2026-08-27 | in-house |
| 302440.KS SK bioscience Co.,Ltd. | COMPLIANT | 2026-08-27 | in-house |
| SUPRIYA.BO Supriya Lifescience Limited | COMPLIANT | 2026-08-27 | in-house |
| TLX Telix Pharmaceuticals Limited American Depositary Shares | COMPLIANT | 2026-11-09 | provider |
| 600645.SS Vcanbio Cell & Gene Engineering Corp., Ltd | COMPLIANT | 2026-08-26 | in-house |
| 688658.SS Youcare Pharmaceutical Group Co., Ltd. | COMPLIANT | 2026-08-27 | in-house |
| 2256.HK Abbisko Cayman Limited | NON-COMPLIANT | 2026-08-27 | in-house |
| ABCL AbCellera Biologics Inc. | NON-COMPLIANT | 2026-08-27 | in-house |
| ACIU AC Immune SA | NON-COMPLIANT | 2026-08-28 | in-house |
| ACTI.ST Active Biotech AB (publ) | NON-COMPLIANT | 2026-09-08 | in-house |
| ADAG Adagene Inc. | NON-COMPLIANT | 2026-08-28 | in-house |
| 4142.TW Adimmune Corporation | NON-COMPLIANT | 2026-08-27 | in-house |
| AGEN Agenus Inc | NON-COMPLIANT | 2026-11-09 | provider |
| 9926.HK Akeso, Inc. | NON-COMPLIANT | 2026-08-27 | in-house |
| ACOG Alpha Cognition Inc. | NON-COMPLIANT | 2026-11-09 | provider |
| 9966.HK Alphamab Oncology | NON-COMPLIANT | 2026-08-27 | in-house |
| ATHE Alterity Therapeutics Limited | NON-COMPLIANT | 2026-08-28 | in-house |
| ACE.ST Ascelia Pharma AB (publ) | NON-COMPLIANT | 2026-09-08 | in-house |
| 6855.HK Ascentage Pharma Group International | NON-COMPLIANT | 2026-08-27 | in-house |
| BINV.ST BioInvent International AB (publ) | NON-COMPLIANT | 2026-08-27 | in-house |
| 22UA.DE BioNTech SE | NON-COMPLIANT | 2026-08-27 | in-house |
| 2137.HK Brii Biosciences Limited | NON-COMPLIANT | 2026-08-28 | in-house |
| CANTA.ST Cantargia AB (publ) | NON-COMPLIANT | 2026-08-28 | in-house |
| CTX.WA Captor Therapeutics Spolka Akcyjna | NON-COMPLIANT | 2026-08-28 | in-house |
| 300294.SZ China Resources Boya Bio-pharmaceutical Group Co.,Ltd | NON-COMPLIANT | 2026-08-26 | in-house |
| 688443.SS Chongqing Genrix Biopharmaceutical Co., Ltd. | NON-COMPLIANT | 2026-08-26 | in-house |
| 300122.SZ Chongqing Zhifei Biological Products Co., Ltd. | NON-COMPLIANT | 2026-08-26 | in-house |
| 0775.HK CK Life Sciences Int'l., (Holdings) Inc. | NON-COMPLIANT | 2026-08-27 | in-house |
| CRSP CRISPR Therapeutics AG | NON-COMPLIANT | 2026-08-28 | in-house |
| HELP.NE Cybin D/B/A Helus Pharma | NON-COMPLIANT | 2026-08-28 | in-house |
| 002030.SZ Daan Gene Co., Ltd. | NON-COMPLIANT | 2026-08-26 | in-house |
| DBVT DBV Technologies - ADR | NON-COMPLIANT | 2026-11-09 | provider |
| DFTX Definium Therapeutics, Inc. | NON-COMPLIANT | 2026-08-28 | in-house |
| DMYD-B.ST Diamyd Medical AB (publ) | NON-COMPLIANT | 2026-08-28 | in-house |
| DCAL.NS Dishman Carbogen Amcis Limited | NON-COMPLIANT | 2026-08-27 | in-house |
| 9606.HK Duality Biotherapeutics, Inc. | NON-COMPLIANT | 2026-08-27 | in-house |
| EGTX.ST Egetis Therapeutics AB (publ) | NON-COMPLIANT | 2026-08-28 | in-house |
| EPRX.TO Eupraxia Pharmaceuticals Inc. | NON-COMPLIANT | 2026-08-28 | in-house |
| GANX Gain Therapeutics Inc | NON-COMPLIANT | 2026-11-09 | provider |
| GLMD Galmed Pharmaceuticals Ltd. | NON-COMPLIANT | 2026-08-28 | in-house |
| 2595.HK GenFleet Therapeutics (Shanghai) Inc. | NON-COMPLIANT | 2026-08-28 | in-house |
| SIGHT.PA GenSight Biologics S.A. | NON-COMPLIANT | 2026-09-08 | in-house |
| GHRS GH Research PLC | NON-COMPLIANT | 2026-08-28 | in-house |
| HNSA.ST Hansa Biopharma AB (publ) | NON-COMPLIANT | 2026-08-27 | in-house |
| IDYA Ideaya Biosciences Inc | NON-COMPLIANT | 2026-11-09 | provider |
| IDIA.SW Idorsia Ltd | NON-COMPLIANT | 2026-08-28 | in-house |
| IMTX Immatics N.V | NON-COMPLIANT | 2026-11-09 | provider |
| IMMX Immix Biopharma Inc | NON-COMPLIANT | 2026-11-09 | provider |
| 1541.HK ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | NON-COMPLIANT | 2026-08-27 | in-house |
Showing 1–100 of 755
Keep going
All halal Healthcare stocks
The same question one level wider, across every industry in the sector.
Screen this industry yourself
Filter by methodology, verdict and strictness across the whole universe.
How these verdicts are reached
The ratio thresholds and business-activity rules behind every row above.
Every industry we screen
Browse the other industries HTR covers.